The Surfers evaluate a draft report from the Institute for Clinical and Economic Review (ICER) on resmetirom and obeticholic acid for NASH. This high-caliber session offers a plethora of practical considerations around accessing approved NASH pharmacotherapies for those most in need.
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking discussion on increasing incidence of Type-2 diabetes among adolescents. The group shares ideas around what’s contributing to this swelling burden and how to dampen its devastating impact.
The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking impromptu session on what’s happening thus far for the Fatty Liver field in 2023. They discuss emerging stories in science and policy which elicit responses ranging from positive excitement to head-scratching concern.
This conversation From the Vault visits the 2022 Liver Conference coverage of pediatric NASH and NAFLD with guest, Naim Alkhouri.
The Surfers explore the metabolic implications behind patients living longer with Fatty Livers. Guests Naim Alkhouri and Rohit Kohli go on to describe the unique challenges associated with use of NITs in the pediatric population.
The Surfers discuss increasing incidence of pediatric and adolescent Fatty Liver disease. This is a sobering session which introduces a critical issue intimate to two extremely knowledgeable guests, Naim Alkhouri and Rohit Kohli.
Lead author Jeffrey Lazarus and co-author Jörn Schattenberg join Stephen Harrison, Louise Campbell and Roger Green to discuss the groundbreaking paper “Advancing the Global Health Agenda for NAFLD.” This conversation focuses on the question “What’s Next,” which makes the scale of the challenge clear and compelling.
AASLD has published new practice guidance on the clinical assessment and management of NAFLD. Surfers Jörn Schattenberg, Louise Campbell and Roger Green are joined by Ken Cusi to discuss a new Rising Tide podcast series and final thoughts on the guidance document.
AASLD has published new practice guidance on the clinical assessment and management of NAFLD. Surfers Jörn Schattenberg, Louise Campbell and Roger Green are joined by Ken Cusi to discuss its influence outside of the US.
AASLD has published new practice guidance on the clinical assessment and management of NAFLD. Surfers Jörn Schattenberg, Louise Campbell and Roger are joined by Ken Cusi to discuss the document’s practical impact on patients today.
